Unaudited Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023	$ 344,349	$ 46	$ 512,401	$ 665	$ (168,763)
Beginning balance (in shares) at Dec. 31, 2023		46,252,440
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	320,059	$ 5	320,054
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		5,397,301
Exercise of common stock options	4,404	$ 1	4,403
Exercise of common stock options (in shares)		441,368
Shares issued under employee stock purchase plan	473		473
Shares issued under employee stock purchase plan (in shares)		63,070
Vesting of restricted shares	10		10
Vesting of restricted shares (in shares)		8,036
Stock-based compensation	11,382		11,382
Unrealized gain (loss) on available-for-sale securities, net	(2,281)			(2,281)
Net loss	(20,719)				(20,719)
Ending balance at Jun. 30, 2024	657,677	$ 52	848,723	(1,616)	(189,482)
Ending balance (in shares) at Jun. 30, 2024		52,162,215
Beginning balance at Mar. 31, 2024	655,763	$ 51	839,759	(524)	(183,523)
Beginning balance (in shares) at Mar. 31, 2024		51,840,571
Exercise of common stock options	2,747	$ 1	2,746
Exercise of common stock options (in shares)		255,086
Shares issued under employee stock purchase plan	473		473
Shares issued under employee stock purchase plan (in shares)		63,070
Issuance costs	(17)		(17)
Vesting of restricted shares	5		5
Vesting of restricted shares (in shares)		3,488
Stock-based compensation	5,757		5,757
Unrealized gain (loss) on available-for-sale securities, net	(1,092)			(1,092)
Net loss	(5,959)				(5,959)
Ending balance at Jun. 30, 2024	657,677	$ 52	848,723	(1,616)	(189,482)
Ending balance (in shares) at Jun. 30, 2024		52,162,215
Beginning balance at Dec. 31, 2024	1,022,781	$ 59	1,258,316	2,163	(237,757)
Beginning balance (in shares) at Dec. 31, 2024		59,064,606
Exercise of common stock options	$ 1,076		1,076
Exercise of common stock options (in shares)	140,533	140,533
Shares issued under employee stock purchase plan	$ 779		779
Shares issued under employee stock purchase plan (in shares)		90,175
Issuance of common stock upon settlement of restricted stock units (in shares)		2,500
Stock-based compensation	21,662		21,662
Unrealized gain (loss) on available-for-sale securities, net	1,584			1,584
Net loss	(57,366)				(57,366)
Ending balance at Jun. 30, 2025	990,516	$ 59	1,281,833	3,747	(295,123)
Ending balance (in shares) at Jun. 30, 2025		59,297,814
Beginning balance at Mar. 31, 2025	1,012,469	$ 59	1,269,919	3,756	(261,265)
Beginning balance (in shares) at Mar. 31, 2025		59,168,490
Exercise of common stock options	175		175
Exercise of common stock options (in shares)		36,649
Shares issued under employee stock purchase plan	779		779
Shares issued under employee stock purchase plan (in shares)		90,175
Issuance of common stock upon settlement of restricted stock units (in shares)		2,500
Stock-based compensation	10,960		10,960
Unrealized gain (loss) on available-for-sale securities, net	(9)			(9)
Net loss	(33,858)				(33,858)
Ending balance at Jun. 30, 2025	$ 990,516	$ 59	$ 1,281,833	$ 3,747	$ (295,123)
Ending balance (in shares) at Jun. 30, 2025		59,297,814